Holen Sie sich die Stockscreener-App
15.71
4.73%
0.71
Schlusskurs vom Vortag:
$15.00
Offen:
$14.85
24-Stunden-Volumen:
143.49K
Relative Volume:
1.32
Marktkapitalisierung:
$257.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.5244
EPS:
-29.96
Netto-Cashflow:
-
1W Leistung:
+5.79%
1M Leistung:
+19.47%
6M Leistung:
+1,147%
1J Leistung:
+1,147%
1-Tages-Spanne:
$14.68
$15.97
1-Wochen-Bereich:
$12.71
$16.36
52-Wochen-Spanne:
$11.75
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Firmenname
Shoulder Innovations Inc
Sektor
Branche
Telefon
616-566-0286
Adresse
13827 PORT SHELDON STREET, HOLLAND
Vergleichen Sie SI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
15.71 | 257.71M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | BTIG Research | Buy |
| 2025-08-25 | Eingeleitet | Goldman | Buy |
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-25 | Eingeleitet | Piper Sandler | Overweight |
| 2023-03-06 | Herabstufung | Compass Point | Neutral → Sell |
| 2023-03-06 | Herabstufung | Wedbush | Neutral → Underperform |
| 2023-03-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Herabstufung | Compass Point | Buy → Neutral |
| 2023-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-01-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Bestätigt | Wedbush | Outperform |
| 2022-12-05 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-10-26 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-06 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Eingeleitet | BTIG Research | Buy |
| 2022-06-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-06-09 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Eingeleitet | BofA Securities | Buy |
| 2022-01-20 | Hochstufung | Goldman | Neutral → Buy |
| 2021-12-16 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-11-08 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-06-14 | Eingeleitet | Goldman | Neutral |
| 2021-01-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Eingeleitet | Wedbush | Outperform |
| 2020-12-17 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Eingeleitet | Craig Hallum | Buy |
| 2020-10-16 | Eingeleitet | Compass Point | Buy |
| 2020-03-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Eingeleitet | Barclays | Overweight |
| 2019-11-18 | Eingeleitet | Compass Point | Buy |
Alle ansehen
Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten
US-based Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Shoulder Innovations (NYSE:SI) Receives "Buy" Rating from BTIG Research - MarketBeat
Shoulder Innovations (NYSE:SI) Posts Quarterly Earnings Results - MarketBeat
Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON) - The Globe and Mail
Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Strong Market Position and Growth Potential Drive Buy Rating for Shoulder Innovations, Inc. - TipRanks
Shoulder Innovations Reports Strong Revenue Growth Amid Losses - TipRanks
SHOULDER INNOVATIONS, INC. SEC 10-Q Report - TradingView
Shoulder Innovations, Inc. Appoints Rick Buchholz to Its Board of Directors - MarketScreener
Shoulder Innovations expects 2025 revenue of $42 million$44 million - MarketScreener
Medical equipment maker Shoulder Innovations Q2 revenue up 33% - MarketScreener
Shoulder Innovations Reports Second Quarter 2025 Financial Results - WV News
Healthcare Pulse: Quarterly Results Due Sept. 9, 2025 - RTTNews
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Shoulder Innovations, Inc.'s Quiet Period To Expire on September 9th (NYSE:SI) - MarketBeat
Earnings Preview: SI to Report Financial Results Pre-market on September 09 - 富途牛牛
Shoulder Innovations, Inc.’s Quiet Period Set To End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations initiated with an Overweight at Piper Sandler - MSN
Shoulder Innovations, Inc. shares rise 5.18% intraday after Thermo Fisher Scientific completes acquisition of Solventum's Purification & Filtration business. - AInvest
Shoulder Innovations, Inc.’s Quiet Period Will End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations initiated with a Buy at Goldman Sachs - MSN
Shoulder Innovations (NYSE:SI) Rating Lowered to Sell at Wall Street Zen - Defense World
Shoulder Innovations shares rise 2.97% intraday after announcing Q2 2025 earnings release and conference participation. - AInvest
Shoulder Innovations Soars 6.68% on Market Momentum - AInvest
Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025 - The Malaysian Reserve
Brokerages Set Shoulder Innovations, Inc. (NYSE:SI) Target Price at $19.60 - Defense World
Shoulder Innovations to Release Q2 2025 Financials and Host Fireside Chat at Morgan Stanley Conference. - AInvest
Morgan Stanley Initiates Coverage of Shoulder Innovations with Overweight Rating - AInvest
Shoulder Innovations initiated with a Buy at Jefferies - MSN
Shoulder Innovations (NYSE:SI) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World
Strong Buy Rating for Shoulder Innovations, Inc. Driven by Market Leadership and High Growth Potential - TipRanks
Shoulder Innovations stock initiated with Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Buy Rating for Shoulder Innovations, Inc.: Strong Growth Potential in Shoulder Replacement Market - TipRanks
Heartflow, Inc. shares rise 4.03% intraday after Goldman Sachs and Morgan Stanley initiate coverage on Shoulder Innovations. - AInvest
Piper Sandler initiates coverage on Shoulder Innovations with Overweight rating, PT $18. - AInvest
Shoulder Innovations stock initiated with Buy rating by BTIG - Investing.com
Jefferies Initiates Shoulder Innovations at Buy With $19 Price Target - MarketScreener
Goldman Sachs Initiates Shoulder Innovations at Buy With $20 Price Target - MarketScreener
Jefferies initiates Shoulder Innovations stock with Buy rating on market share gains - Investing.com Canada
Piper Sandler initiates Shoulder Innovations stock with Overweight rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Shoulder Innovations stock with Buy rating - Investing.com Canada
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com Australia
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
Shoulder Innovations (NYSE:SI) Reaches New 52-Week HighHere's Why - MarketBeat
Finanzdaten der Shoulder Innovations Inc-Aktie (SI)
Es liegen keine Finanzdaten für Shoulder Innovations Inc (SI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):